Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-16

Clinical Trial Update: RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing low-dose clomiphene to high-dose gonadotropin protocols for IVF poor responders was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)
  • Gonadotropins (FSH/hMG) (gonadotropins)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Infertility | Phase 4 | Status: WITHDRAWN